937 related articles for article (PubMed ID: 16219884)
1. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
; Danesh J; Lewington S; Thompson SG; Lowe GD; Collins R; Kostis JB; Wilson AC; Folsom AR; Wu K; Benderly M; Goldbourt U; Willeit J; Kiechl S; Yarnell JW; Sweetnam PM; Elwood PC; Cushman M; Psaty BM; Tracy RP; Tybjaerg-Hansen A; Haverkate F; de Maat MP; Fowkes FG; Lee AJ; Smith FB; Salomaa V; Harald K; Rasi R; Vahtera E; Jousilahti P; Pekkanen J; D'Agostino R; Kannel WB; Wilson PW; Tofler G; Arocha-Piñango CL; Rodriguez-Larralde A; Nagy E; Mijares M; Espinosa R; Rodriquez-Roa E; Ryder E; Diez-Ewald MP; Campos G; Fernandez V; Torres E; Marchioli R; Valagussa F; Rosengren A; Wilhelmsen L; Lappas G; Eriksson H; Cremer P; Nagel D; Curb JD; Rodriguez B; Yano K; Salonen JT; Nyyssönen K; Tuomainen TP; Hedblad B; Lind P; Loewel H; Koenig W; Meade TW; Cooper JA; De Stavola B; Knottenbelt C; Miller GJ; Cooper JA; Bauer KA; Rosenberg RD; Sato S; Kitamura A; Naito Y; Palosuo T; Ducimetiere P; Amouyel P; Arveiler D; Evans AE; Ferrieres J; Juhan-Vague I; Bingham A; Schulte H; Assmann G; Cantin B; Lamarche B; Després JP; Dagenais GR; Tunstall-Pedoe H; Woodward M; Ben-Shlomo Y; Davey Smith G; Palmieri V; Yeh JL; Rudnicka A; Ridker P; Rodeghiero F; Tosetto A; Shepherd J; Ford I; Robertson M; Brunner E; Shipley M; Feskens EJ; Kromhout D; Dickinson A; Ireland B; Juzwishin K; Kaptoge S; Lewington S; Memon A; Sarwar N; Walker M; Wheeler J; White I; Wood A
JAMA; 2005 Oct; 294(14):1799-809. PubMed ID: 16219884
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
; Erqou S; Kaptoge S; Perry PL; Di Angelantonio E; Thompson A; White IR; Marcovina SM; Collins R; Thompson SG; Danesh J
JAMA; 2009 Jul; 302(4):412-23. PubMed ID: 19622820
[TBL] [Abstract][Full Text] [Related]
3. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.
Danesh J; Collins R; Appleby P; Peto R
JAMA; 1998 May; 279(18):1477-82. PubMed ID: 9600484
[TBL] [Abstract][Full Text] [Related]
4. Major lipids, apolipoproteins, and risk of vascular disease.
; Di Angelantonio E; Sarwar N; Perry P; Kaptoge S; Ray KK; Thompson A; Wood AM; Lewington S; Sattar N; Packard CJ; Collins R; Thompson SG; Danesh J
JAMA; 2009 Nov; 302(18):1993-2000. PubMed ID: 19903920
[TBL] [Abstract][Full Text] [Related]
5. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a), fibrinogen and vascular mortality in an elderly northern Italian population.
D'Angelo A; Ruotolo G; Garancini P; Sampietro F; Mazzola G; Calori G
Haematologica; 2006 Dec; 91(12):1613-20. PubMed ID: 17145597
[TBL] [Abstract][Full Text] [Related]
7. LDL cholesterol and the development of stroke subtypes and coronary heart disease in a general Japanese population: the Hisayama study.
Imamura T; Doi Y; Arima H; Yonemoto K; Hata J; Kubo M; Tanizaki Y; Ibayashi S; Iida M; Kiyohara Y
Stroke; 2009 Feb; 40(2):382-8. PubMed ID: 19095987
[TBL] [Abstract][Full Text] [Related]
8. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women.
Fung TT; Chiuve SE; McCullough ML; Rexrode KM; Logroscino G; Hu FB
Arch Intern Med; 2008 Apr; 168(7):713-20. PubMed ID: 18413553
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5113 patients with transient ischemic attack and minor ischemic stroke.
Rothwell PM; Howard SC; Power DA; Gutnikov SA; Algra A; van Gijn J; Clark TG; Murphy MF; Warlow CP
Stroke; 2004 Oct; 35(10):2300-5. PubMed ID: 15345800
[TBL] [Abstract][Full Text] [Related]
10. Age-related macular degeneration and risk of coronary heart disease: the Atherosclerosis Risk in Communities Study.
Wong TY; Tikellis G; Sun C; Klein R; Couper DJ; Sharrett AR
Ophthalmology; 2007 Jan; 114(1):86-91. PubMed ID: 17198851
[TBL] [Abstract][Full Text] [Related]
11. Ideal Cardiovascular Health and Incident Cardiovascular Disease: Heterogeneity Across Event Subtypes and Mediating Effect of Blood Biomarkers: The PRIME Study.
Gaye B; Tafflet M; Arveiler D; Montaye M; Wagner A; Ruidavets JB; Kee F; Evans A; Amouyel P; Ferrieres J; Empana JP
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042430
[TBL] [Abstract][Full Text] [Related]
12. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study.
Lawlor DA; Smith GD; Rumley A; Lowe GD; Ebrahim S
Thromb Haemost; 2005 May; 93(5):955-63. PubMed ID: 15886815
[TBL] [Abstract][Full Text] [Related]
13. Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality.
Daviglus ML; Stamler J; Pirzada A; Yan LL; Garside DB; Liu K; Wang R; Dyer AR; Lloyd-Jones DM; Greenland P
JAMA; 2004 Oct; 292(13):1588-92. PubMed ID: 15467061
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.
; Kaptoge S; Di Angelantonio E; Lowe G; Pepys MB; Thompson SG; Collins R; Danesh J
Lancet; 2010 Jan; 375(9709):132-40. PubMed ID: 20031199
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis.
Homocysteine Studies Collaboration
JAMA; 2002 Oct 23-30; 288(16):2015-22. PubMed ID: 12387654
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
18. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study.
Chien KL; Hsu HC; Sung FC; Su TC; Chen MF; Lee YT
Atherosclerosis; 2005 Nov; 183(1):147-55. PubMed ID: 16154134
[TBL] [Abstract][Full Text] [Related]
19. Non-high-density lipoprotein cholesterol and the development of coronary heart disease and stroke subtypes in a general Japanese population: the Hisayama Study.
Imamura T; Doi Y; Ninomiya T; Hata J; Nagata M; Ikeda F; Mukai N; Hirakawa Y; Yoshida D; Fukuhara M; Kitazono T; Kiyohara Y
Atherosclerosis; 2014 Apr; 233(2):343-348. PubMed ID: 24530960
[TBL] [Abstract][Full Text] [Related]
20. Does elevated plasma fibrinogen increase the risk of coronary heart disease? Evidence from a meta-analysis of genetic association studies.
Smith GD; Harbord R; Milton J; Ebrahim S; Sterne JA
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2228-33. PubMed ID: 16123313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
